{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:47:38Z","timestamp":1793155658428,"version":"4.5.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>\n                    Neutral lipid storage disease with myopathy (NLSDM) is an ultra-rare autosomal recessive lipid metabolism disorder caused by\n                    <jats:italic>PNPLA2<\/jats:italic>\n                    variants, leading to defective adipose triglyceride lipase (ATGL) function and pathological triglyceride accumulation in multiple tissues. Fewer than 150 cases have been reported worldwide, and the clinical spectrum remains incompletely defined. A 57-year-old Moroccan man presented with diabetes, hearing loss, cataracts, hypertrophic cardiomyopathy, and asymmetric weakness. Whole-body muscle MRI revealed severe fatty infiltration of the supraspinatus muscles in the upper limbs and asymmetric right biceps femoris and left lateral gastrocnemius muscle with a patchy pattern in the lower limbs. A deltoid muscle biopsy revealed vacuoles filled with lipids. Peripheral blood smear analysis showed Jordans\u2019 anomaly. Next-generation sequencing disclosed the novel homozygous c.1043del, p.Phe348SerfsTer18\n                    <jats:italic>PNPLA2<\/jats:italic>\n                    frameshift variant predicted to disrupt the adipose triglyceride lipase (ATGL) patatin domain. Bioinformatics protein modeling predicted disruption of the patatin domain and global structural instability, likely abolishing enzymatic activity. Western blotting performed on patient-derived muscle tissue revealed a truncated ATGL protein, functionally validating the truncating effect of this novel variant. This case broadens the phenotypic and molecular understanding of NLSDM.\n                  <\/jats:p>","DOI":"10.3389\/fgene.2026.1701218","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T22:10:21Z","timestamp":1779747021000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: a novel PNPLA2 homozygous frameshift variant causing severe neutral lipid storage disease with myopathy (NLSDM) in a Moroccan patient"],"prefix":"10.3389","volume":"17","author":[{"given":"Elena","family":"Faedo","sequence":"first","affiliation":[{"name":"Reference Center for Neuromuscular Disorders, APHP Henri Mondor University Hospital","place":["Cr\u00e9teil, France"]},{"name":"Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal and Infantile Sciences (DINOGMI), University of Genoa","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Marcela","family":"Araujo Chumacero","sequence":"additional","affiliation":[{"name":"Hospital Nacional Edgardo Rebagliati Martins","place":["Lima, Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Missaglia","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Biochemistry and Molecular Biology, CRIBENS, Catholic University of Sacred Heart","place":["Milan, Italy"]},{"name":"Department of Psychology, Catholic University of Sacred Heart","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Lunati-Rozie","sequence":"additional","affiliation":[{"name":"Reference Center for Neuromuscular Disorders, APHP Henri Mondor University Hospital","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Severa","sequence":"additional","affiliation":[{"name":"Reference Center for Neuromuscular Disorders, APHP Henri Mondor University Hospital","place":["Cr\u00e9teil, France"]},{"name":"University Paris Est Cr\u00e9teil, Inserm, U955, IMRB","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Onn\u00e9e","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Est Cr\u00e9teil Val de Marne","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bornale","family":"Das","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Est Cr\u00e9teil Val de Marne","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Martegani","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Biochemistry and Molecular Biology, CRIBENS, Catholic University of Sacred Heart","place":["Milan, Italy"]},{"name":"Department of Psychology, Catholic University of Sacred Heart","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemie","family":"Lafage","sequence":"additional","affiliation":[{"name":"Reference Center for Neuromuscular Disorders, APHP Henri Mondor University Hospital","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"El Bejjani","sequence":"additional","affiliation":[{"name":"Reference Center for Neuromuscular Disorders, APHP Henri Mondor University Hospital","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Barka","sequence":"additional","affiliation":[{"name":"Reference Center for Neuromuscular Disorders, APHP Henri Mondor University Hospital","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Gobin-Limballe","sequence":"additional","affiliation":[{"name":"H\u00f4pital Universitaire Necker-Enfants Malades","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouchra","family":"Badaoui","sequence":"additional","affiliation":[{"name":"Reference Center for Neuromuscular Disorders, APHP Henri Mondor University Hospital","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pascal","family":"Lefaucheur","sequence":"additional","affiliation":[{"name":"Clinical Neurophysiology Unit, Henri Mondor University Hospital, AP-HP","place":["Cr\u00e9teil, France"]},{"name":"EA 4391, ENT Team, Paris-Est Cr\u00e9teil University","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Tavian","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Biochemistry and Molecular Biology, CRIBENS, Catholic University of Sacred Heart","place":["Milan, Italy"]},{"name":"Department of Psychology, Catholic University of Sacred Heart","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Malfatti","sequence":"additional","affiliation":[{"name":"Reference Center for Neuromuscular Disorders, APHP Henri Mondor University Hospital","place":["Cr\u00e9teil, France"]},{"name":"University Paris Est Cr\u00e9teil, Inserm, U955, IMRB","place":["Cr\u00e9teil, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1756286419843359","DOI":"10.1177\/1756286419843359","article-title":"Metabolic lipid muscle disorders: biomarkers and treatment","volume":"12","author":"Angelini","year":"2019","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094427","article-title":"Muscle MR imaging in tubular aggregate myopathy","author":"Beltrame","year":"2014"},{"key":"B3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1136\/bmj.1.5957.553","article-title":"Neutral-lipid storage disease: a new disorder of lipid metabolism","volume":"1","author":"Chanarin","year":"1975","journal-title":"BMJ"},{"key":"B4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5414\/NPP29351","article-title":"A novel PNPLA2 mutation causes neutral lipid storage disease with myopathy (NLSDM) presenting muscular dystrophic features with lipid storage and rimmed vacuoles","volume":"29","author":"Chen","year":"2010","journal-title":"NP"},{"key":"B5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archderm.1974.01630080059017","article-title":"Ichthyosiform dermatosis with systemic lipidosis","volume":"110","author":"Dorfman","year":"1974","journal-title":"Arch. Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/ng1951","article-title":"The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy","volume":"39","author":"Fischer","year":"2007","journal-title":"Nat. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jocn.2018.10.046","article-title":"Neutral lipid storage disease with myopathy and dropped head syndrome. Report of a new variant susceptible of treatment with late diagnosis","volume":"58","author":"Garcia","year":"2018","journal-title":"J. Clin. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1007\/s00415-017-8498-8","article-title":"Muscle MRI in neutral lipid storage disease (NLSD)","volume":"264","author":"Garibaldi","year":"2017","journal-title":"J. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrgastro.2017.32","article-title":"Lipid droplets and liver disease: from basic biology to clinical implications","volume":"14","author":"Gluchowski","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"100960","DOI":"10.1016\/j.ymgmr.2023.100960","article-title":"A novel homozygous missense mutation in PNPLA2 in a patient manifesting primary triglyceride deposit cardiomyovasculopathy","volume":"34","author":"Hara","year":"2023","journal-title":"Mol. Genet. Metabolism Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.nmd.2014.04.001","article-title":"A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review","volume":"24","author":"Kaneko","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1210\/jc.2007-2247","article-title":"The lack of the C-Terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets","volume":"93","author":"Kobayashi","year":"2008","journal-title":"J. Clin. Endocrinol. and Metabolism"},{"key":"B13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.plipres.2010.10.004","article-title":"Lipolysis \u2013 a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores","volume":"50","author":"Lass","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.nmd.2018.04.010","article-title":"Neutral lipid storage disease with myopathy: further phenotypic characterization of a rare PNPLA2 variant","volume":"28","author":"Latimer","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1086\/324121","article-title":"Mutations in CGI-58, the gene encoding a new protein of the Esterase\/Lipase\/Thioesterase subfamily, in chanarin-dorfman syndrome","volume":"69","author":"Lef\u00e8vre","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ymgme.2015.05.001","article-title":"Novel missense mutations in PNPLA2 causing late onset and clinical heterogeneity of neutral lipid storage disease with myopathy in three siblings","volume":"115","author":"Missaglia","year":"2015","journal-title":"Mol. Genet. Metabolism"},{"key":"B17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nmd.2017.01.011","article-title":"Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement","volume":"27","author":"Missaglia","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"10645","DOI":"10.4081\/ejtm.2022.10645","article-title":"Neutral lipid storage disease with myopathy: a 10-year follow-up case report","volume":"32","author":"Missaglia","year":"2022","journal-title":"Eur. J. Transl. Myol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"E1540","DOI":"10.1210\/jc.2013-1444","article-title":"Metabolic consequences of adipose triglyceride lipase deficiency in humans: an in vivo Study in patients with neutral lipid storage disease with myopathy","volume":"98","author":"Natali","year":"2013","journal-title":"J. Clin. Endocrinol. and Metabolism"},{"key":"B20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13023-017-0646-9","article-title":"Neutral Lipid Storage Diseases: clinical\/genetic features and natural history in a large cohort of Italian patients","volume":"12","author":"Pennisi","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jaccas.2020.03.021","article-title":"ATGL deficiency-induced triglyceride deposit cardiomyovasculopathy requiring heart transplant","volume":"2","author":"Rajani","year":"2020","journal-title":"JACC Case Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000508346","article-title":"Neutral lipid storage disease associated with the PNPLA2 gene: case report and literature review","volume":"83","author":"Samukawa","year":"2020","journal-title":"Eur. Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.nmd.2023.12.012","article-title":"Neutral lipid storage disease with myopathy: clinicopathological and genetic features of nine Iranian patients","volume":"35","author":"Shahriyari","year":"2024","journal-title":"Neuromuscul. Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.visres.2017.03.007","article-title":"Whole exome sequencing identification of novel candidate genes in patients with proliferative diabetic retinopathy","volume":"139","author":"Ung","year":"2017","journal-title":"Vis. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1161\/CIRCRESAHA.113.300944","article-title":"Effects of bezafibrate treatment in a patient and a carrier with mutations in the PNPLA2 gene, causing neutral lipid storage disease with myopathy","volume":"112","author":"Van De Weijer","year":"2013","journal-title":"Circulation Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1186\/s12891-024-07772-9","article-title":"Two PNPLA2 heterozygous mutations result in neutral lipid storage disease with myopathy: a case report","volume":"25","author":"Yang","year":"2024","journal-title":"BMC Musculoskelet. Disord."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1016\/j.ymthe.2025.06.023","article-title":"AAV9-mediated gene supplementation therapy prevents and rescues arrhythmogenic cardiomyopathy in Pnpla2-mutated mice","volume":"33","author":"Zhang","year":"2025","journal-title":"Mol. Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12881-018-0683-9","article-title":"Novel PNPLA2 gene mutation in a child causing neutral lipid storage disease with myopathy","volume":"19","author":"Zheng","year":"2018","journal-title":"BMC Med. Genet."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1701218\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T22:10:23Z","timestamp":1779747023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1701218\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":29,"alternative-id":["10.3389\/fgene.2026.1701218"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2026.1701218","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"article-number":"1701218"}}